1400 BROADFIELD BLVD., HOUSTON, TX
Impact Biomedical Inc. Approves Reverse Stock Split Proposal
Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Limited (f/k/a Dr Ashleys Limited)
Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited
Amendment to Merger and Share Exchange Agreement with Dr Ashleys Limited
Submission of Matters to a Vote of Security Holders
Other Events
News, Material Contracts
Announce Strategic Merger
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus Filed Pursuant to Rule 425
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Amended Registration Statement for Securities
Amended Registration of Securities
Preliminary Information Statement
Definitive Proxy Statement
Definitive Information Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
S-8 POS